Insulin Pump Use in Type 2 Diabetes
- 1 June 2010
- journal article
- research article
- Published by Mary Ann Liebert Inc in Diabetes Technology & Therapeutics
- Vol. 12 (S1), S17-17
- https://doi.org/10.1089/dia.2009.0192
Abstract
Continuous subcutaneous insulin infusion (CSII) for type 2 diabetes mellitus (T2DM) is a promising therapy, but the clinical evidence supporting it is mixed. Large randomized controlled trials have concluded that CSII was equivalent to multiple daily injections (MDI), whereas smaller trials have concluded that CSII was superior. Simpler insulin regimens of CSII have been investigated for T2DM and may lead to improved outcomes. Future directions in this area include simpler insulin pumps and the use of concentrated insulins (U-500), neither of which has left the feasibility stage of research. CSII may be appropriate for some people with T2DM, especially those for whom MDI therapy has failed.Keywords
This publication has 19 references indexed in Scilit:
- Insulin Pump Therapy in Patients with Type 2 Diabetes Safely Improved Glycemic Control Using a Simple Insulin Dosing RegimenDiabetes Technology & Therapeutics, 2010
- Three-Year Efficacy of Complex Insulin Regimens in Type 2 DiabetesNew England Journal of Medicine, 2009
- Continuous Subcutaneous Insulin Infusion Versus Multiple Daily Insulin Injections in Type 2 Diabetes: A Meta-analysisExperimental and Clinical Endocrinology & Diabetes, 2009
- Insulin and glucose profiles during continuous subcutaneous insulin infusion compared with injection of a long‐acting insulin in Type 2 diabetes1Diabetic Medicine, 2008
- Clinical Efficacy and Patient Satisfaction with U-500 Insulin Pump Therapy in Patients with Type 2 DiabetesEndocrine Practice, 2007
- Long-term treatment combining continuous subcutaneous insulin infusion with oral hypoglycaemic agents is effective in type 2 diabetesDiabetes & Metabolism, 2007
- Effectiveness of Intensive Insulin Therapy by Multiple Daily Injections and Continuous Subcutaneous Infusion: A Comparison Study in Type 2 Diabetes with Conventional Insulin Regimen FailureHormone and Metabolic Research, 2007
- Use of U-500 Regular Insulin by Continuous Subcutaneous Insulin Infusion in Patients with Type 2 Diabetes and Severe Insulin ResistanceEndocrine Practice, 2006
- A Clinical Trial of Continuous Subcutaneous Insulin Infusion Versus Multiple Daily Injections in Older Adults With Type 2 DiabetesDiabetes Care, 2005
- Abnormal Patterns of Insulin Secretion in Non-Insulin-Dependent Diabetes MellitusNew England Journal of Medicine, 1988